The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1 , Pages 127-132 , July 2005

Progression of self-reported symptoms in laboratory animal allergy

  • Leslie Elliott, PhD

      Affiliations

    • From the Department of Epidemiology, University of North Carolina at Chapel Hill
    • Corresponding Author InformationReprint requests: Leslie Elliott, PhD, c/o the Department of Epidemiology, CB-7435, University of North Carolina, Chapel Hill, NC 27599-7435.
    • ,
  • Dick Heederik, PhD

      Affiliations

    • Institute of Risk Assessment Sciences, Utrecht University
    • ,
  • Steve Marshall, PhD

      Affiliations

    • From the Department of Epidemiology, University of North Carolina at Chapel Hill
    • ,
  • David Peden, MD

      Affiliations

    • Center for Asthma and Lung Biology, Chapel Hill
    • ,
  • Dana Loomis, PhD

      Affiliations

    • From the Department of Epidemiology, University of North Carolina at Chapel Hill

Received 2 February 2005 ,Revised 18 March 2005 ,Accepted 29 March 2005.

  • Image Result

    A, Symptom distributions of workers on initial questionnaires (workers with LAA at baseline) or at first report of symptoms (workers who developed LAA during the study). B, Symptom distributions of wo

    A, Symptom distributions of workers on initial questionnaires (workers with LAA at baseline) or at first report of symptoms (workers who developed LAA during the study). B, Symptom distributions of workers on final questionnaires.

  • Image Result
    Survival curves comparing development of asthma between workers with and without LAA symptoms.

    Survival curves comparing development of asthma between workers with and without LAA symptoms.

 Dr Elliott was supported by training grant no. T42/CCT422952 from the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Dr Elliott also worked as a consultant to GlaxoSmithKline, Inc.Dr Peden was supported by grant no. R01 HL62624, “Endotoxin and bronchial inflammation in asthma.”Disclosure of potential conflict of interest: L. Elliott worked as a consultant for GlaxoSmithKline from 2000-2003. D. Peden has consultant arrangements with GlaxoSmithKline, Novartis, and Genentech. All other authors—none disclosed.

PII: S0091-6749(05)00699-8

doi: 10.1016/j.jaci.2005.03.038

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 1 , Pages 127-132 , July 2005

Article Tools

* Image Usage & Resolution